BELLEVUE ASSET MANAGEMENT, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
BELLEVUE ASSET MANAGEMENT, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,404
+5.2%
380.0%0.00%0.0%
Q2 2023$3,235
+2.9%
380.0%0.00%0.0%
Q1 2023$3,144
+18.5%
38
+11.8%
0.00%0.0%
Q4 2022$2,654
-11.5%
340.0%0.00%0.0%
Q3 2022$3,000
+50.0%
340.0%0.00%
+100.0%
Q2 2022$2,0000.0%340.0%0.00%0.0%
Q1 2022$2,0000.0%34
-19.0%
0.00%0.0%
Q4 2021$2,000
-33.3%
42
-6.7%
0.00%
-50.0%
Q3 2021$3,000
+200.0%
45
+114.3%
0.00%
+100.0%
Q2 2021$1,000
-66.7%
21
-8.7%
0.00%
-50.0%
Q1 2021$3,0000.0%23
-11.5%
0.00%0.0%
Q4 2020$3,000260.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders